Publications
Found 2 results
Filters: Author is L.H. Fan [Clear All Filters]
, “Autogenous radiocephalic hemodialysis access in patients with small caliber cephalic veins after expansion with a Fogarty catheter”, vol. 13, pp. 3520-3526, 2014.
, “MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3”, vol. 12, pp. 1012-1021, 2013.
Ambros V and Chen X (2007). The regulation of genes and genomes by small RNAs. Development 134: 1635-1641.
http://dx.doi.org/10.1242/dev.002006
PMid:17409118
Berezikov E, Guryev V, van de Belt J, Wienholds E, et al. (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24.
http://dx.doi.org/10.1016/j.cell.2004.12.031
PMid:15652478
Chen C, Ridzon DA, Broomer AJ, Zhou Z, et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33: e179.
http://dx.doi.org/10.1093/nar/gni178
PMid:16314309 PMCid:1292995
Chen H, Chen Q, Fang M and Mi Y (2009). Regulatory effect on the proliferation of the leukemic cell HL-60 by miRNA- 181b through MLK2 science in China. Life Sci. 39: 1034-1040.
de Yébenes VG, Belver L, Pisano DG, Gonzalez S, et al. (2008). miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205: 2199-2206.
http://dx.doi.org/10.1084/jem.20080579
PMid:18762567 PMCid:2556787
Debernardi S, Skoulakis S, Molloy G, Chaplin T, et al. (2007). MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21: 912-916.
PMid:17330104
Gibson W, Green A, Bullard RS, Eaddy AC, et al. (2007). Inhibition of PAX2 expression results in alternate cell death pathways in prostate cancer cells differing in p53 status. Cancer Lett. 248: 251-261.
http://dx.doi.org/10.1016/j.canlet.2006.08.007
PMid:16996682
Jonler M and Pedersen KV (2007). Diagnosis, evaluation and follow-up of patients with prostatic cancer. Ugeskr. Laeger 169: 1889-1891.
PMid:17553363
Livak KJ and Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
http://dx.doi.org/10.1006/meth.2001.1262
PMid:11846609
Marcucci G, Radmacher MD, Maharry K, Mrózek K, et al. (2008). MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358: 1919-1928.
http://dx.doi.org/10.1056/NEJMoa074256
PMid:18450603
Meltzer PS (2005). Cancer genomics: small RNAs with big impacts. Nature 435: 745-746.
http://dx.doi.org/10.1038/435745a
PMid:15944682
Nakajima G, Hayashi K, Xi Y, Kudo K, et al. (2006). Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics 3: 317-324.
PMid:18172508 PMCid:2170889
Ozen M, Creighton CJ, Ozdemir M and Ittmann M (2008). Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27: 1788-1793.
http://dx.doi.org/10.1038/sj.onc.1210809
PMid:17891175
Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, et al. (2006). Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 66: 11590-11593.
http://dx.doi.org/10.1158/0008-5472.CAN-06-3613
PMid:17178851
Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, et al. (2007). MicroRNA expression profiling in prostate cancer. Cancer Res. 67: 6130-6135.
http://dx.doi.org/10.1158/0008-5472.CAN-07-0533
PMid:17616669
Prueitt RL, Yi M, Hudson RS, Wallace TA, et al. (2008). Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68: 1152-1164.
http://dx.doi.org/10.1002/pros.20786
PMid:18459106 PMCid:2597330
Rajewsky N (2006). microRNA target predictions in animals. Nat. Genet. 38 Suppl: S8-13.
http://dx.doi.org/10.1038/ng1798
PMid:16736023
Schaefer A, Jung M, Mollenkopf HJ, Wagner I, et al. (2010). Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 126: 1166-1176.
PMid:19676045
Shi L, Cheng Z, Zhang J, Li R, et al. (2008). hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 1236: 185-193.
http://dx.doi.org/10.1016/j.brainres.2008.07.085
PMid:18710654
Spahn M, Kneitz S, Scholz CJ, Stenger N, et al. (2010). Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int. J. Cancer 127: 394-403.
PMid:19585579
Stark A, Brennecke J, Bushati N, Russell RB, et al. (2005). Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123: 1133-1146.
http://dx.doi.org/10.1016/j.cell.2005.11.023
PMid:16337999
Volinia S, Calin GA, Liu CG, Ambs S, et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103: 2257-2261.
http://dx.doi.org/10.1073/pnas.0510565103
PMid:16461460 PMCid:1413718
Xu L and Wang GM (2007). The progress and current situation in the management of moderate and far advanced prostate cancer. Int. J. Urol. Nephrol. 27: 773.
Zhang B and Farwell MA (2008). microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J. Cell Mol. Med. 12: 3-21.
http://dx.doi.org/10.1111/j.1582-4934.2007.00196.x
PMid:18088390